Latest News on Pfizer Inc. (PFE) Stock

  • Pfizer Inc. (PFE) Closes 0.06% Down on the Day for June 28 [June 28 2017 02:30 PM]
  • Pfizer Inc. (PFE) Closes 0.06% Down on the Day for June 28   Equities.com - 6 hours ago Shares of Pfizer Inc. (PFE) ended the trading day Wednesday at $33.75, representing a move of -0.06%, or $0.02 per share, on volume of 14.76 million shares. Read more about this Pfizer Inc. (PFE) news
  • Just the Facts on Pfizer Inc. (PFE) [June 28 2017 11:00 AM]
  • Just the Facts on Pfizer Inc. (PFE)   StockNewsJournal - 9 hours ago Pfizer Inc. (PFE) is an interesting player in the Healthcare space, with a focus on Drug Manufacturers - Major. The stock has been active on the tape, currently trading at $33.77, down from yesterday's close by -0.79%. Brokerages Set Pfizer, Inc. (PFE) Target Price at $37.29 - The Cerbat Gem  EPS for Pfizer Inc. ... Read more about this Pfizer Inc. (PFE) news


  • Pfizer breaks ground on new $236 million Chesterfield research campus [June 27 2017 04:39 PM]
  • Pfizer breaks ground on new $236 million Chesterfield research campus   STLtoday.com - Jun 27, 2017 CHESTERFIELD • After a competitive, multiyear process to identify a home for the project, pharmaceutical giant Pfizer Inc. broke ground Tuesday on a research campus in Chesterfield where it will hone development of medicine and vaccines. The facility ... Read more about this Pfizer Inc. (PFE) news


  • Pfizer: Negative Signs? [June 26 2017 12:30 PM]
  • Pfizer: Negative Signs?   Seeking Alpha - Jun 26, 2017 While the industry is believed to be on the rise, Pfizer Inc reported a decline in sales for 1Q17. The best-selling drug of Pfizer, close to the patent expiration date is “Lyrica” whose U.S. Read more about this Pfizer Inc. (PFE) news
  • Pfizer’s Profitability in 1Q17 [June 28 2017 07:36 AM]
  • Pfizer's gross margin for 1Q17 was 81.0%, a 0.70% rise compared to 80.3% in 1Q16. Read more about this Pfizer Inc. (PFE) news
  • Pfizer’s Geographical Performance in 1Q17 [June 28 2017 06:06 AM]
  • The Innovative Health segment reported a 9.0% rise in 1Q17 revenues compared to 1Q16 revenues from sales in the US markets. Read more about this Pfizer Inc. (PFE) news
  • Pfizer’s Segment Performance in 1Q17 [June 28 2017 04:36 AM]
  • Pfizer Innovative Health contributed $7.4 billion, or about 58.0% of Pfizer's total revenues in 1Q17. Read more about this Pfizer Inc. (PFE) news
  • [$$] Cancer Drug Startup Vivace Therapeutics Raises $40 Million [June 28 2017 03:15 AM]
  • Two former executives of successful venture-backed company LEAD Therapeutics are now leaders of Vivace Therapeutics Inc., a cancer drug startup that has raised $40 million in Series A and B financing. Read more about this Pfizer Inc. (PFE) news

Looking for Market Opportunties?


Today's Most Active Stocks
Today's Biggest Price % Gainers
Today's Biggest Price % Losers
Today's Unusual Rising Volume Stocks
Today's Unusual Falling Volume Stocks
Research Reports
Earning Calendar
ETF Center